Skip to Main Content

Immediate Pause in the Administration of the Johnson and Johnson COVID-19 vaccine


The FDA is recommending an immediate pause in the administration of the Johnson and Johnson (Janssen) COVID-19 vaccine due reports of six cases of a rare and serious clot (cerebral venous sinus thrombosis)…there has been one associated death…for context, 6.8 million doses of the Johnson and Johnson COVID-19 vaccine have been administered…a link to the FDA statement is below.

Consequently, all CommonSpirit Health facilities should immediately halt administration of the Johnson and Johnson COVID-19 vaccine…there will be an emergency session of the Advisory Committee on Immunization Practices (ACIP) tomorrow (Wednesday, April 14) to review the data…additional guidance might be forthcoming after ACIP meets.

Please be sure all of your sites are aware of this development…our pharmacy and patient safety teams are working to provide additional information today.

Read the full story at the FDA Website.

Publish Date: 

Wednesday, April 14, 2021

News

Reflecting on a devastating milestone: Over one million lives lost to COVID-19

MAY 20, 2022

Dr. Thomas McGinn, CommonSpirit Executive Vice President, Physician Enterprise, reflects on one million lives lost to COVID-19.

Read More Additional information about Reflecting on a devastating milestone: Over one million lives lost to COVID-19

CommonSpirit Health Announces FY2022 Q3 Results

MAY 13, 2022

CommonSpirit Health has released financial results for its fiscal year 2022 third quarter.

Read More Additional information about CommonSpirit Health Announces FY2022 Q3 Results

CNO Kathy Sanford: Our approach to nursing must change

MAY 10, 2022

Chief Nursing Officer Kathy Sanford discusses how CommonSpirit Health is changing our approach to nursing by taking proactive steps to support nurses through their career continuum and shape the future workforce.

Read More Additional information about CNO Kathy Sanford: Our approach to nursing must change